Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma

Neth J Med. 1984;27(2):25-30.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects
  • Vinblastine / analogs & derivatives
  • Vindesine

Substances

  • Vinblastine
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan
  • Vindesine
  • Prednisone

Supplementary concepts

  • CAPE protocol